Alembic Pharmaceuticals Limited (APLLTD.NS)

Home
APLLTD.NS
Financials

896.55 (INR) • At close May 9, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Assets:
Current Assets:
Cash & Cash Equivalents Numbers are in millions	1,202.1	754.8	610.9	980.6	718.4	1,990.7	837.5	1,530.8	4,508.291	268.256	239.613	161.06	470.805	62.893
Short Term Investments Numbers are in millions	0	166.4	316.2	1,869.7	0	0	121.8	503.4	-846.162	0	0	0	0	0
Cash and Short Term Investments Numbers are in millions	1,202.1	921.2	610.9	2,850.3	718.4	1,990.7	959.3	1,530.8	4,508.291	268.256	239.613	161.06	470.805	62.893
Net Receivables Numbers are in millions	10,248.4	10,464	8,071.3	3,485.8	8,647.5	4,889.2	0	3,388.2	3,504.8	4,811.429	4,204.351	3,492.2	3,813.749	3,133.01
Inventory Numbers are in millions	16,435.4	14,752.7	16,097	14,861.5	11,875.3	9,672.6	7,339.3	6,327.5	5,775.798	3,827.706	3,107.782	2,668.333	2,587.415	2,192.319
Other Current Assets Numbers are in millions	2,899.7	3,128.7	3,828.7	5,322.4	3,386.3	3,025.1	9,948.9	2,478.1	1,401.6	0	1,545.96	3,492.2	3.544	30.686
Total Current Assets Numbers are in millions	30,785.6	29,100.2	28,607.9	25,779	24,627.5	19,577.3	18,247.5	13,210.6	15,065.632	8,907.391	7,551.746	6,321.593	6,875.513	5,418.908
Non-Current Assets:
Property, Plant & Equipment, Net Numbers are in millions	30,710.5	29,997.3	39,472.6	36,480.3	30,990.1	24,399.9	18,377.6	11,686.8	8,237.453	5,947.316	4,176.298	3,764.833	3,260.616	2,984.957
Goodwill Numbers are in millions	0	0	0	0	0	36	37.7	0	435.585	352.807	0	0	0	0
Intangible Assets Numbers are in millions	0	0	1,548.2	3,229.5	2,990.2	2,662.7	1,619.7	270	0	0	0	0	0	0
Goodwill and Intangible Assets Numbers are in millions	0	0	1,548.2	3,229.5	2,990.2	2,698.7	1,657.4	270	435.585	352.807	0	0	0	0
Long Term Investments Numbers are in millions	930.2	963.3	1,184	493.1	176.2	487.6	294.6	498.8	867.3	22.641	33.557	33.028	0	0
Tax Assets Numbers are in millions	0	1,230.1	58.8	1,108	1,106.6	148.5	121.8	552.9	238.1	-22.641	0	0	0	0
Other Non-Current Assets Numbers are in millions	2,029.5	537.4	348.8	-0.1	-0.1	467.3	711.4	647.7	-250.268	1,204.161	416.416	358.788	382.912	32.617
Total Non-Current Assets Numbers are in millions	33,670.2	32,728.1	42,612.4	41,310.8	35,263	28,202	21,162.8	13,656.2	9,528.17	7,504.284	4,626.271	4,156.649	3,643.528	3,017.574
Total Assets Numbers are in millions	64,455.8	61,828.3	71,220.3	67,089.8	59,890.5	47,777.6	39,410.5	26,866.8	24,593.802	16,411.675	12,178.018	10,478.242	10,519.041	8,436.482
Liabilities & Equity:
Current Liabilities:
Account Payables Numbers are in millions	7,356.4	6,798.1	7,063.9	6,687.7	6,259.3	6,443.4	3.2	11.5	8.8	9.6	8.831	5.565	5.431	1,385.67
Short Term Debt Numbers are in millions	4,502.8	6,527.9	6,449.7	3,121.8	8,704	6,291.3	1,774.1	732.4	1,564.178	2,446.988	571.774	1,162.569	1,394.577	0
Tax Payables Numbers are in millions	0	0	0	21.5	0	36.1	0	97.9	92.6	0	0	0	0	0
Deferred Revenue Numbers are in millions	0	2,187.9	3,651.8	2,998.7	2,133.8	8,340.6	94.7	5,891	6,100.624	4,383.339	3,893.561	3,243.349	356.634	0
Other Current Liabilities Numbers are in millions	2,690.8	855.4	2,959.5	2,742.2	418.9	2,125.5	9,059.2	5,779.4	6,008.736	6,623.664	3,898.504	3,248.152	3,948.38	750.644
Total Current Liabilities Numbers are in millions	14,550	16,369.3	17,165.3	12,808.4	17,516	14,896.3	11,234.9	6,787.5	7,674.314	6,840.903	4,479.109	4,416.286	5,348.388	2,136.314
Non-Current Liabilities:
Long Term Debt Numbers are in millions	628.8	692.3	721.4	2,720.3	9,602.9	4,993	5,000	0	0	188	522.2	705.347	894.663	3,279.076
Deferred Revenue Non-Current Numbers are in millions	0	-831.4	-1,976.9	855.2	745.1	520.3	616.6	0	0	93.615	66.806	60.606	53.904	0
Deferred Tax Liabilities Non-Current Numbers are in millions	0	831.4	1,976.9	42.1	121.9	187.5	354.4	369.3	501.287	314.334	227.17	138.969	95.29	53.746
Other Non-Current Liabilities Numbers are in millions	1,095	1,062.1	958.1	36.2	122	187.7	354.5	572.2	914.092	128.439	354.207	266.576	122.908	-1,746.933
Total Non-Current Liabilities Numbers are in millions	1,723.8	1,754.3	1,679.5	3,611.7	10,470	5,701	5,971.1	1,067.1	914.092	724.388	943.213	1,032.529	1,220.669	3,347.33
Total Liabilities Numbers are in millions	16,273.8	18,123.6	18,844.8	16,420.1	27,986	20,597.3	17,206	7,854.6	8,588.406	7,565.291	5,422.322	5,448.815	6,569.057	5,483.644
Equity:
Preferred Stock Numbers are in millions	0	0	0	0	52,508.7	44,066.9	0	0	0	0	0	0	0	0
Common Stock Numbers are in millions	393.1	393.1	393.1	393.1	377	377	377	377	377.032	377.032	377.032	377.032	377.032	377.032
Retained Earnings Numbers are in millions	40,272.6	35,684.4	25,543.9	24,241	15,386.4	12,868.7	9,370	7,181.8	7,136.2	8,373.566	6,234.995	4,582.435	822.974	0
Accumulated Other Comprehensive Income/Loss Numbers are in millions	32.4	335.4	18,808.8	18,513.8	-4,951.5	-3,513.8	-2,455.4	-4,554.4	-3,878.237	-3,141.88	-2,681.209	-2,282.569	-1,950.891	-1,615.453
Other Total Stockholders Equity Numbers are in millions	7,483.9	7,483.9	26,438.5	27,033.6	-31,126.5	-26,610.6	14,909.8	11,379.9	8,388.9	4,034.482	4,436.419	3,458.299	2,749.978	393.037
Total Shareholders Equity Numbers are in millions	48,182	43,704.7	52,375.5	51,276.1	32,194.1	27,188.2	22,201.4	19,011.1	16,005.396	8,846.384	6,755.696	5,029.427	3,949.984	2,952.838
Total Equity Numbers are in millions	48,182	43,704.7	52,375.5	50,669.7	31,904.5	27,180.3	22,204.5	19,012.2	16,005.396	8,846.384	6,755.696	5,029.427	3,949.984	2,952.838
Total Liabilities & Shareholders Equity Numbers are in millions	64,455.8	61,828.3	71,220.3	67,089.8	59,890.5	47,777.6	39,410.5	26,866.8	24,593.802	16,411.675	12,178.018	10,478.242	10,519.041	8,436.482

Alembic Pharmaceuticals Limited

NSE:APLLTD.NS Add to watchlist

NSE:APLLTD.NS